2-[4-(4-Chloro-1,2-diphenylbut-1-enyl)phenoxy]-N,N-dimethylethanamine (BioDeep_00000175361)
human metabolite blood metabolite
代谢物信息卡片
2-[4-(4-chloro-1,2-diphenylbut-1-enyl)phenoxy]-N,N-dimethylethanamine
化学式: C26H28ClNO (405.18593080000005)
中文名称:
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C1=CC=CC=C1)C1=CC=CC=C1
InChI: InChI=1S/C26H28ClNO/c1-28(2)19-20-29-24-15-13-23(14-16-24)26(22-11-7-4-8-12-22)25(17-18-27)21-9-5-3-6-10-21/h3-16H,17-20H2,1-2H3
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
1 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, Susanne Bäck, Adam Yasgar, Emily S Wires, Carina Danchik, Xiaokang Yan, Hideaki Yano, Lei Shi, Kuo-Jen Wu, Amy Q Wang, Dingyin Tao, Gergely Zahoránszky-Kőhalmi, Xin Hu, Xin Xu, David Maloney, Alexey V Zakharov, Ganesha Rai, Fumihiko Urano, Mikko Airavaara, Oksana Gavrilova, Ajit Jadhav, Yun Wang, Anton Simeonov, Brandon K Harvey. A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
Cell reports.
2021 04; 35(4):109040. doi:
10.1016/j.celrep.2021.109040. [PMID: 33910017] - Tobie D Lee, Olivia W Lee, Kyle R Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, Bethilehem G Tebase, Carleen Klumpp-Thomas, Robert W Robey, Suresh V Ambudkar, Min Shen, Michael M Gottesman, Matthew D Hall. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Molecular pharmacology.
2019 11; 96(5):629-640. doi:
10.1124/mol.119.115964. [PMID: 31515284] - Luigi Gennari, Daniela Merlotti, Konstantinos Stolakis, Ranuccio Nuti. Pharmacokinetic evaluation of toremifene and its clinical implications for the treatment of osteoporosis.
Expert opinion on drug metabolism & toxicology.
2012 Apr; 8(4):505-13. doi:
10.1517/17425255.2012.665873. [PMID: 22356442] - Monica Mazzarino, Maria Cristina Braganò, Xavier de la Torre, Francesco Molaioni, Francesco Botrè. Relevance of the selective oestrogen receptor modulators tamoxifen, toremifene and clomiphene in doping field: endogenous steroids urinary profile after multiple oral doses.
Steroids.
2011 Nov; 76(12):1400-6. doi:
10.1016/j.steroids.2011.06.005. [PMID: 21745489] - Monica Mazzarino, Xavier de la Torre, Francesco Botrè. Urinary excretion profiles of toremifene metabolites by liquid chromatography-mass spectrometry. Towards targeted analysis to relevant metabolites in doping control.
Analytical and bioanalytical chemistry.
2011 Aug; 401(2):529-41. doi:
10.1007/s00216-011-4695-y. [PMID: 21380606] - Keisei Anan, Shoshu Mitsuyama, Yasuhiro Yanagita, Morihiko Kimura, Hiroyoshi Doihara, Kansei Komaki, Mikihiro Kusama, Tadashi Ikeda. Effects of toremifene and anastrozole on serum lipids and bone metabolism in postmenopausal females with estrogen receptor-positive breast cancer: the results of a 2-year multicenter open randomized study.
Breast cancer research and treatment.
2011 Aug; 128(3):775-81. doi:
10.1007/s10549-011-1608-x. [PMID: 21638048] - C Gómez, O J Pozo, R Diaz, J V Sancho, E Vilaroca, J P Salvador, M P Marco, F Hernandez, J Segura, R Ventura. Mass spectrometric characterization of urinary toremifene metabolites for doping control analyses.
Journal of chromatography. A.
2011 Jul; 1218(29):4727-37. doi:
10.1016/j.chroma.2011.05.073. [PMID: 21683367] - Hein Van Poppel, Bertrand Tombal. Cardiovascular risk during hormonal treatment in patients with prostate cancer.
Cancer management and research.
2011 Mar; 3(?):49-55. doi:
10.2147/cmr.s16893. [PMID: 21448299] - Jianghai Lu, Xiaobing Wang, Youxuan Xu, Ying Dong, Shuming Yang, Yun Wu, Yang Qin, Moutian Wu. Mass spectrometric characterization of toremifene metabolites in human urine by liquid chromatography-tandem mass spectrometry with different scan modes.
The Analyst.
2011 Feb; 136(3):467-72. doi:
10.1039/c0an00487a. [PMID: 21113546] - Tine M Comhair, Sonia C Garcia Caraballo, Cornelis Hc Dejong, Wouter H Lamers, S Eleonore Köhler. Dietary cholesterol, female gender and n-3 fatty acid deficiency are more important factors in the development of non-alcoholic fatty liver disease than the saturation index of the fat.
Nutrition & metabolism.
2011 Jan; 8(?):4. doi:
10.1186/1743-7075-8-4. [PMID: 21261989] - Masataka Sawaki, Ai Idota, Hiroki Uchida, Sumiyo Noda, Shigenori Sato, Toyone Kikumori, Tsuneo Imai. The effect of toremifene on lipid metabolism compared with that of tamoxifen in vitro.
Gynecologic and obstetric investigation.
2011; 71(3):213-6. doi:
10.1159/000322372. [PMID: 21196696] - Whitney M Ellefson, Ashley M Lakner, Alicia Hamilton, Iain H McKillop, Herbert L Bonkovsky, Nury M Steuerwald, Yvette M Huet, Laura W Schrum. Neonatal androgenization exacerbates alcohol-induced liver injury in adult rats, an effect abrogated by estrogen.
PloS one.
2011; 6(12):e29463. doi:
10.1371/journal.pone.0029463. [PMID: 22206017] - Pawel Szulc. Biochemical bone turnover markers and osteoporosis in older men: where are we?.
Journal of osteoporosis.
2011; 2011(?):704015. doi:
10.4061/2011/704015. [PMID: 22220284] - Alex Zwiers, Michiel van den Heuvel, Jean Smeets, Samantha Rutherford. Assessment of the potential for displacement interactions with sugammadex: a pharmacokinetic-pharmacodynamic modelling approach.
Clinical drug investigation.
2011; 31(2):101-11. doi:
10.2165/11584730-000000000-00000. [PMID: 21067251] - Matthew R Smith, Ronald A Morton, K Gary Barnette, Paul R Sieber, S Bruce Malkowicz, Domingo Rodriguez, Michael L Hancock, Mitchell S Steiner. Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer.
The Journal of urology.
2010 Oct; 184(4):1316-21. doi:
10.1016/j.juro.2010.06.022. [PMID: 20723926] - Howard S Kim, Stephen J Freedland. Androgen deprivation therapy in prostate cancer: anticipated side-effects and their management.
Current opinion in supportive and palliative care.
2010 Sep; 4(3):147-52. doi:
10.1097/spc.0b013e32833bd913. [PMID: 20592607] - Takeshi Tominaga, Izo Kimijima, Morihiko Kimura, Yuichi Takatsuka, Shigemitsu Takashima, Yasuo Nomura, Fujio Kasumi, Akihiro Yamaguchi, Norikazu Masuda, Shinzaburo Noguchi, Nobuoki Eshima. Effects of toremifene and tamoxifen on lipid profiles in post-menopausal patients with early breast cancer: interim results from a Japanese phase III trial.
Japanese journal of clinical oncology.
2010 Jul; 40(7):627-33. doi:
10.1093/jjco/hyq021. [PMID: 20382637] - Sinikka Oksa, Tiina Luukkaala, Johanna U Mäenpää. Toremifene use does not alter serum inhibin A and B levels during mid-luteal phase in women with premenstrual mastalgia.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
2010 Feb; 26(2):114-7. doi:
10.3109/09513590903215441. [PMID: 20074020] - Kanji Minamoto, Toshio Ikeda. [A case of advanced breast cancer with multiple bone metastases responding to docetaxel and high-dose toremifene as fourth-line chemo-endocrine therapy].
Gan to kagaku ryoho. Cancer & chemotherapy.
2009 Dec; 36(13):2627-30. doi:
. [PMID: 20009468] - Sorin J Brull, Mohamed Naguib. Selective reversal of muscle relaxation in general anesthesia: focus on sugammadex.
Drug design, development and therapy.
2009 Sep; 3(?):119-29. doi:
10.2147/dddt.s3868. [PMID: 19920928] - D A Aliev, V A Azizov, T A Sadygova, R S Zeĭnalov, I N Musaev. [Lipid metabolism disorders at the breast cancer patients receiving hormonotherapy].
Georgian medical news.
2009 Mar; ?(168):44-7. doi:
". [PMID: 19359718] - Paul E Goss, Shangle Qi, Haiqing Hu. Comparing the effects of atamestane, toremifene and tamoxifen alone and in combination, on bone, serum lipids and uterus in ovariectomized rats.
The Journal of steroid biochemistry and molecular biology.
2009 Feb; 113(3-5):233-40. doi:
10.1016/j.jsbmb.2009.01.005. [PMID: 19429427] - Maurizio Cutolo. Androgens in rheumatoid arthritis: when are they effectors?.
Arthritis research & therapy.
2009; 11(5):126. doi:
10.1186/ar2804. [PMID: 19804618] - Luigi Gennari, Daniela Merlotti, Vincenzo De Paola, Giuseppe Martini, Ranuccio Nuti. Bazedoxifene for the prevention of postmenopausal osteoporosis.
Therapeutics and clinical risk management.
2008 Dec; 4(6):1229-42. doi:
10.2147/tcrm.s3476. [PMID: 19337430] - Bertrand Tombal. Words of wisdom. Re: toremifene improves lipid profiles in men receiving androgen-deprivation therapy for prostate cancer: interim analysis of a multicenter phase III study.
European urology.
2008 Nov; 54(5):1202-3. doi:
10.1016/j.eururo.2008.07.067. [PMID: 19051383] - Reagan L Ross, Michelle R Serock, Raouf A Khalil. Experimental benefits of sex hormones on vascular function and the outcome of hormone therapy in cardiovascular disease.
Current cardiology reviews.
2008 Nov; 4(4):309-22. doi:
10.2174/157340308786349462. [PMID: 20066139] - Lee R Jackson, Kwok L Cheung, Aman U Buzdar, John F R Robertson. Arzoxifene: the evidence for its development in the management of breast cancer.
Core evidence.
2008 Jul; 2(4):251-8. doi:
". [PMID: 21221190] - Matthew R Smith, S Bruce Malkowicz, Franklin Chu, John Forrest, Paul Sieber, K Gary Barnette, Domingo Rodriquez, Mitchell S Steiner. Toremifene improves lipid profiles in men receiving androgen-deprivation therapy for prostate cancer: interim analysis of a multicenter phase III study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2008 Apr; 26(11):1824-9. doi:
10.1200/jco.2007.13.5517. [PMID: 18398147] - Monica Mazzarino, Ilaria Fiacco, Xavier de la Torre, Francesco Botrè. A mass spectrometric approach for the study of the metabolism of clomiphene, tamoxifen and toremifene by liquid chromatography time-of-flight spectroscopy.
European journal of mass spectrometry (Chichester, England).
2008; 14(3):171-80. doi:
10.1255/ejms.921. [PMID: 18708697] - Dimitrios Farmakiotis, Christos Farmakis, David Rousso, Anargyros Kourtis, Ilias Katsikis, Dimitrios Panidis. The beneficial effects of toremifene administration on the hypothalamic-pituitary-testicular axis and sperm parameters in men with idiopathic oligozoospermia.
Fertility and sterility.
2007 Oct; 88(4):847-53. doi:
10.1016/j.fertnstert.2006.12.038. [PMID: 17412336] - Paul E Goss, Shangle Qi, Haiqing Hu, Angela M Cheung. The effects of atamestane and toremifene alone and in combination compared with letrozole on bone, serum lipids and the uterus in an ovariectomized rat model.
Breast cancer research and treatment.
2007 Jul; 103(3):293-302. doi:
10.1007/s10549-006-9381-y. [PMID: 17063268] - Cora J Fong, Lyle D Burgoon, Kurt J Williams, Agnes L Forgacs, Timothy R Zacharewski. Comparative temporal and dose-dependent morphological and transcriptional uterine effects elicited by tamoxifen and ethynylestradiol in immature, ovariectomized mice.
BMC genomics.
2007 Jun; 8(?):151. doi:
10.1186/1471-2164-8-151. [PMID: 17555576] - Matthew R Smith. Androgen deprivation therapy for prostate cancer: new concepts and concerns.
Current opinion in endocrinology, diabetes, and obesity.
2007 Jun; 14(3):247-54. doi:
10.1097/med.0b013e32814db88c. [PMID: 17940447] - S Fontana, R Ghilardi, A Barbaglio, P Amaddeo, F Faldi, S Pericotti. Male breast cancer with mandibular metastasis. A case report.
Minerva stomatologica.
2007 Apr; 56(4):225-30. doi:
NULL. [PMID: 17452960] - Luigi Gennari, Daniela Merlotti, Fabrizio Valleggi, Giuseppe Martini, Ranuccio Nuti. Selective estrogen receptor modulators for postmenopausal osteoporosis: current state of development.
Drugs & aging.
2007; 24(5):361-79. doi:
10.2165/00002512-200724050-00002. [PMID: 17503894] - G E Christodoulakos, I V Lambrinoudaki, D C Botsis. The cardiovascular effects of selective estrogen receptor modulators.
Annals of the New York Academy of Sciences.
2006 Dec; 1092(?):374-84. doi:
10.1196/annals.1365.034. [PMID: 17308162] - Noel N Kim, Miljan Stankovic, Abdullah Armagan, Tulay T Cushman, Irwin Goldstein, Abdulmaged M Traish. Effects of tamoxifen on vaginal blood flow and epithelial morphology in the rat.
BMC women's health.
2006 Sep; 6(?):14. doi:
10.1186/1472-6874-6-14. [PMID: 16970814] - Luigi Gennari. Lasofoxifene: a new type of selective estrogen receptor modulator for the treatment of osteoporosis.
Drugs of today (Barcelona, Spain : 1998).
2006 Jun; 42(6):355-67. doi:
10.1358/dot.2006.42.6.973583. [PMID: 16845439] - Harold A Harvey, Morihiko Kimura, Alajos Hajba. Toremifene: an evaluation of its safety profile.
Breast (Edinburgh, Scotland).
2006 Apr; 15(2):142-57. doi:
10.1016/j.breast.2005.09.007. [PMID: 16289904] - Eric A Ariazi, Jennifer L Ariazi, Fernando Cordera, V Craig Jordan. Estrogen receptors as therapeutic targets in breast cancer.
Current topics in medicinal chemistry.
2006; 6(3):181-202. doi:
. [PMID: 16515478] - Chang Gong, Erwei Song, Weijuan Jia, Li Qin, Jujiang Guo, Haixia Jia, Xiaoqu Hu, Fengxi Su. A double-blind randomized controlled trial of toremifen therapy for mastalgia.
Archives of surgery (Chicago, Ill. : 1960).
2006 Jan; 141(1):43-7. doi:
10.1001/archsurg.141.1.43. [PMID: 16415410] - A Kallio, A Zheng, J Dahllund, K M Heiskanen, P Härkönen. Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells.
Apoptosis : an international journal on programmed cell death.
2005 Dec; 10(6):1395-410. doi:
10.1007/s10495-005-2137-z. [PMID: 16215679] - Toshiaki Saeki, Takashi Tsuruo, Wakao Sato, Kiyoshiro Nishikawsa. Drug resistance in chemotherapy for breast cancer.
Cancer chemotherapy and pharmacology.
2005 Nov; 56 Suppl 1(?):84-9. doi:
10.1007/s00280-005-0106-4. [PMID: 16273361] - R Erkkola, L Mattila, T Powles, J Heikkinen, B Toivola, P Korhonen, M Mustonen. Bone mineral density and lipid changes during 5 years of follow-up in a study of prevention of breast cancer with toremifene in healthy, high-risk pre- and post-menopausal women.
Breast cancer research and treatment.
2005 Oct; 93(3):277-87. doi:
10.1007/s10549-005-5701-x. [PMID: 16172794] - N J Bundred. The effects of aromatase inhibitors on lipids and thrombosis.
British journal of cancer.
2005 Aug; 93 Suppl 1(?):S23-7. doi:
10.1038/sj.bjc.6602692. [PMID: 16100522] - Russell C Hovey, Mikiko Asai-Sato, Anni Warri, Barbara Terry-Koroma, Nira Colyn, Erika Ginsburg, Barbara K Vonderhaar. Effects of neonatal exposure to diethylstilbestrol, tamoxifen, and toremifene on the BALB/c mouse mammary gland.
Biology of reproduction.
2005 Feb; 72(2):423-35. doi:
10.1095/biolreprod.104.029769. [PMID: 15470002] - Matthew R Smith. Selective estrogen receptor modulators to prevent treatment-related osteoporosis.
Reviews in urology.
2005; 7 Suppl 3(?):S30-5. doi:
NULL. [PMID: 16985877] - M Kusama, K Miyauchi, H Aoyama, M Sano, M Kimura, S Mitsuyama, K Komaki, H Doihara. Effects of toremifene (TOR) and tamoxifen (TAM) on serum lipids in postmenopausal patients with breast cancer.
Breast cancer research and treatment.
2004 Nov; 88(1):1-8. doi:
10.1007/s10549-004-4384-z. [PMID: 15538040] - Mikihiro Kusama, H Kaise, S Nakayama, D Ota, T Misaka, T Aoki. Crossover trial for lipid abnormality in postmenopausal breast cancer patients during selective estrogen receptor modulators (SERMs) administrations.
Breast cancer research and treatment.
2004 Nov; 88(1):9-16. doi:
10.1007/s10549-004-5449-8. [PMID: 15538041] - L Vehmanen, T Saarto, C Blomqvist, M-R Taskinen, I Elomaa. Tamoxifen treatment reverses the adverse effects of chemotherapy-induced ovarian failure on serum lipids.
British journal of cancer.
2004 Aug; 91(3):476-81. doi:
10.1038/sj.bjc.6601979. [PMID: 15266329] - Kozo Koshizuka, Masaru Serizawa, Norio Hasuda, Kazushige Furuya, Naruaki Mouri, Kunio Takano, Masahiko Matsumoto. [Tamoxifen-induced severe hypertriglyceridemia--report of 3 cases].
Gan to kagaku ryoho. Cancer & chemotherapy.
2004 Jul; 31(7):1109-12. doi:
NULL. [PMID: 15272596] - Yoshihito Saito, Sadao Amano, Mitsuhiko Kashio, Hideo Abe, Youichi Kuboi, Kenichi Sakurai, Nobuhiko Aoki, Satoshi Hata, Nanao Negishi. [A case of breast cancer with multiple bone metastases demonstrating complete remission with high-dose toremifene therapy].
Gan to kagaku ryoho. Cancer & chemotherapy.
2004 Jun; 31(6):911-4. doi:
. [PMID: 15222111] - Sirpa Leppä, Tiina Saarto, Leena Vehmanen, Carl Blomqvist, Inkeri Elomaa. A high serum matrix metalloproteinase-2 level is associated with an adverse prognosis in node-positive breast carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2004 Feb; 10(3):1057-63. doi:
10.1158/1078-0432.ccr-03-0047. [PMID: 14871985] - Jan Heidemann, Hitoshi Ogawa, Mary F Otterson, Vinod B Shidham, David G Binion. Antiangiogenic treatment of mesenteric desmoid tumors with toremifene and interferon alfa-2b: report of two cases.
Diseases of the colon and rectum.
2004 Jan; 47(1):118-22. doi:
10.1007/s10350-003-0019-4. [PMID: 14719159] - S G O'Brien, P Meinhardt, E Bond, J Beck, B Peng, C Dutreix, G Mehring, S Milosavljev, C Huber, R Capdeville, T Fischer. Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome p450 3A4 substrate, in patients with chronic myeloid leukaemia.
British journal of cancer.
2003 Nov; 89(10):1855-9. doi:
10.1038/sj.bjc.6601152. [PMID: 14612892] - I N G Springer, H Terheyden, M A A Suhr, P Warnke, A Dunsche, M Tiemann, Y Açil. Follow-up of collagen crosslink excretion in patients with oral squamous cell carcinoma and analysis of tissue samples.
British journal of cancer.
2003 Nov; 89(9):1722-8. doi:
10.1038/sj.bjc.6601325. [PMID: 14583776] - J Ellmén, P Hakulinen, A Partanen, D F Hayes. Estrogenic effects of toremifene and tamoxifen in postmenopausal breast cancer patients.
Breast cancer research and treatment.
2003 Nov; 82(2):103-11. doi:
10.1023/b:brea.0000003957.54851.11. [PMID: 14692654] - Cora N Sternberg, Nicholas J Vogelzang. Gemcitabine, paclitaxel, pemetrexed and other newer agents in urothelial and kidney cancers.
Critical reviews in oncology/hematology.
2003 Jun; 46 Suppl(?):S105-15. doi:
10.1016/s1040-8428(03)00068-4. [PMID: 12850531] - Mitchell S Steiner, Charlie R Pound. Phase IIA clinical trial to test the efficacy and safety of Toremifene in men with high-grade prostatic intraepithelial neoplasia.
Clinical prostate cancer.
2003 Jun; 2(1):24-31. doi:
10.3816/cgc.2003.n.009. [PMID: 15046680] - Sally G Haskell. Selective estrogen receptor modulators.
Southern medical journal.
2003 May; 96(5):469-76. doi:
10.1097/01.smj.0000051146.93190.4a. [PMID: 12911186] - I N G Springer, H Terheyden, A Dunsche, N Czech, M A A Suhr, M Tiemann, J Hedderich, Y Açil. Collagen crosslink excretion and staging of oral cancer.
British journal of cancer.
2003 Apr; 88(7):1105-10. doi:
10.1038/sj.bjc.6600873. [PMID: 12671712] - Petri Lehenkari, Vilhelmiina Parikka, Timo J Rautiala, Matti Weckström, Johanna Dahllund, Pirkko L Härkönen, H Kalervo Väänänen. The effects of tamoxifen and toremifene on bone cells involve changes in plasma membrane ion conductance.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
2003 Mar; 18(3):473-81. doi:
10.1359/jbmr.2003.18.3.473. [PMID: 12619932] - Karla C Morello, Gregory T Wurz, Michael W DeGregorio. Pharmacokinetics of selective estrogen receptor modulators.
Clinical pharmacokinetics.
2003; 42(4):361-72. doi:
10.2165/00003088-200342040-00004. [PMID: 12648026] - Karla C Morello, Gregory T Wurz, Michael W DeGregorio. SERMs: current status and future trends.
Critical reviews in oncology/hematology.
2002 Jul; 43(1):63-76. doi:
10.1016/s1040-8428(02)00022-7. [PMID: 12098608] - Matthieu Gutman, Steeve Couillard, Jenny Roy, Fernand Labrie, Bernard Candas, Claude Labrie. Comparison of the effects of EM-652 (SCH57068), tamoxifen, toremifene, droloxifene, idoxifene, GW-5638 and raloxifene on the growth of human ZR-75-1 breast tumors in nude mice.
International journal of cancer.
2002 May; 99(2):273-8. doi:
10.1002/ijc.10302. [PMID: 11979444] - Miguel A Valverde, Simon P Hardy, Mario Díaz. Activation of Maxi Cl(-) channels by antiestrogens and phenothiazines in NIH3T3 fibroblasts.
Steroids.
2002 May; 67(6):439-45. doi:
10.1016/s0039-128x(01)00174-x. [PMID: 11960619] - M Mannerström, M Zorn-Kruppa, H Diehl, M Engelke, T Toimela, H Mäenpää, A Huhtala, H Uusitalo, L Salminen, P Pappas, M Marselos, M Mäntylä, E Mäntylä, H Tähti. Evaluation of the cytotoxicity of selected systemic and intravitreally dosed drugs in the cultures of human retinal pigment epithelial cell line and of pig primary retinal pigment epithelial cells.
Toxicology in vitro : an international journal published in association with BIBRA.
2002 Apr; 16(2):193-200. doi:
10.1016/s0887-2333(01)00113-8. [PMID: 11869882] - Sharan Raghow, Massoumeh Z Hooshdaran, Sanjay Katiyar, Mitchell S Steiner. Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model.
Cancer research.
2002 Mar; 62(5):1370-6. doi:
. [PMID: 11888907] - Tamás Nagykálnai. [Selective estrogen receptor modulators (SERMs) in the practice].
Magyar onkologia.
2002; 46(2):165-75. doi:
huon.2002.46.2.0165. [PMID: 12202896] - William K Oh, Judith Manola, Daniel J George, Abby Fierman, Pamela Fontaine-Rothe, Stephanie Morrissey, Judith Prisby, Donald S Kaufman, Charles L Shapiro, Philip W Kantoff, Matthew R Smith. A phase II trial of interferon-alpha and toremifene in advanced renal cell cancer patients.
Cancer investigation.
2002; 20(2):186-91. doi:
10.1081/cnv-120001145. [PMID: 11901538] - A Jukkola, R Bloigu, K Holli, H Joensuu, R Valavaara, J Risteli, G Blanco. Postoperative PINP in serum reflects metastatic potential and poor survival in node-positive breast cancer.
Anticancer research.
2001 Jul; 21(4B):2873-6. doi:
NULL. [PMID: 11712779] - H A Järveläinen, T A Lukkari, S Heinaro, H Sippel, K O Lindros. The antiestrogen toremifene protects against alcoholic liver injury in female rats.
Journal of hepatology.
2001 Jul; 35(1):46-52. doi:
10.1016/s0168-8278(01)00050-2. [PMID: 11495041] - T Doi, K Nishiyama, J Wakasugi, S Ootaki, M Kikuchi, K Kubota, H Yamamoto. [A case of breast cancer with multiple bone metastases improved by high-dose toremifene].
Gan to kagaku ryoho. Cancer & chemotherapy.
2001 Jun; 28(6):839-43. doi:
NULL. [PMID: 11432355] - T Nakatani, G Roy, N Fujimoto, T Asahara, A Ito. Sex hormone dependency of diethylnitrosamine-induced liver tumors in mice and chemoprevention by leuprorelin.
Japanese journal of cancer research : Gann.
2001 Mar; 92(3):249-56. doi:
10.1111/j.1349-7006.2001.tb01089.x. [PMID: 11267934] - D Thiebaud, R J Secrest. Selective estrogen receptor modulators: mechanism of action and clinical experience. Focus on raloxifene.
Reproduction, fertility, and development.
2001; 13(4):331-6. doi:
10.1071/rd00109. [PMID: 11800172] - M Mannerström, H Mäenpää, T Toimela, L Salminen, H Tähti. The phagocytosis of rod outer segments is inhibited by selected drugs in retinal pigment epithelial cell cultures.
Pharmacology & toxicology.
2001 Jan; 88(1):27-33. doi:
10.1034/j.1600-0773.2001.088001027.x. [PMID: 11169158]